156 related articles for article (PubMed ID: 38010374)
21. The prognostic significance of vasohibin-1 expression in patients with prostate cancer.
Kosaka T; Miyazaki Y; Miyajima A; Mikami S; Hayashi Y; Tanaka N; Nagata H; Kikuchi E; Nakagawa K; Okada Y; Sato Y; Oya M
Br J Cancer; 2013 May; 108(10):2123-9. PubMed ID: 23591203
[TBL] [Abstract][Full Text] [Related]
22. The correlation of the expressions of WWOX, LGR5 and vasohibin-1 in epithelial ovarian cancer and their clinical significance.
Yu L; Mao X; Wu S; Zhou L; Song W; Gong X; Wang D
Int J Clin Exp Pathol; 2019; 12(1):327-336. PubMed ID: 31933749
[TBL] [Abstract][Full Text] [Related]
23. NCALD affects drug resistance and prognosis by acting as a ceRNA of CX3CL1 in ovarian cancer.
Dong C; Yin F; Zhu D; Cai X; Chen C; Liu X
J Cell Biochem; 2020 Nov; 121(11):4470-4483. PubMed ID: 32030795
[TBL] [Abstract][Full Text] [Related]
24. Vasohibin-1 as a Novel Prognostic Factor for Head and Neck Squamous Cell Carcinoma.
Torii C; Hida Y; Shindoh M; Akiyama K; Ohga N; Maishi N; Ohiro Y; Ono M; Totsuka Y; Kitagawa Y; Tei K; Sato Y; Hida K
Anticancer Res; 2017 Mar; 37(3):1219-1225. PubMed ID: 28314285
[TBL] [Abstract][Full Text] [Related]
25. Platinum-resistance in epithelial ovarian cancer: an interplay of epithelial-mesenchymal transition interlinked with reprogrammed metabolism.
Leung D; Price ZK; Lokman NA; Wang W; Goonetilleke L; Kadife E; Oehler MK; Ricciardelli C; Kannourakis G; Ahmed N
J Transl Med; 2022 Dec; 20(1):556. PubMed ID: 36463238
[TBL] [Abstract][Full Text] [Related]
26. Vasohibin-1 suppresses colon cancer.
Liu S; Han B; Zhang Q; Dou J; Wang F; Lin W; Sun Y; Peng G
Oncotarget; 2015 Apr; 6(10):7880-98. PubMed ID: 25797264
[TBL] [Abstract][Full Text] [Related]
27. Tubulin carboxypeptidase activity of vasohibin-1 inhibits angiogenesis by interfering with endocytosis and trafficking of pro-angiogenic factor receptors.
Kobayashi M; Wakabayashi I; Suzuki Y; Fujiwara K; Nakayama M; Watabe T; Sato Y
Angiogenesis; 2021 Feb; 24(1):159-176. PubMed ID: 33052495
[TBL] [Abstract][Full Text] [Related]
28. Vasohibin-1 is a new predictor of disease-free survival in operated patients with renal cell carcinoma.
Kanomata N; Sato Y; Miyaji Y; Nagai A; Moriya T
J Clin Pathol; 2013 Jul; 66(7):613-9. PubMed ID: 23543668
[TBL] [Abstract][Full Text] [Related]
29. Prognostic and Immunological Significance of CXCR2 in Ovarian Cancer: A Promising Target for Survival Outcome and Immunotherapeutic Response Assessment.
Ji H; Ren M; Liu T; Sun Y
Dis Markers; 2021; 2021():5350232. PubMed ID: 34840630
[TBL] [Abstract][Full Text] [Related]
30. Vasohibin-2 expressed in human serous ovarian adenocarcinoma accelerates tumor growth by promoting angiogenesis.
Takahashi Y; Koyanagi T; Suzuki Y; Saga Y; Kanomata N; Moriya T; Suzuki M; Sato Y
Mol Cancer Res; 2012 Sep; 10(9):1135-46. PubMed ID: 22826464
[TBL] [Abstract][Full Text] [Related]
31. High preoperative plasma vasohibin-1 concentration predicts better prognosis in patients with non-small cell lung carcinoma.
Watanabe T; Hosaka T; Ohmori-Matsuda K; Suzuki Y; Suzuki H; Yabuki H; Matsuda Y; Noda M; Sakurada A; Okada Y; Sato Y
Health Sci Rep; 2018 Jun; 1(6):e40. PubMed ID: 30623077
[TBL] [Abstract][Full Text] [Related]
32. TIPE2 acts as a tumor suppressor and correlates with tumor microenvironment immunity in epithelial ovarian cancer.
Xu S; Gao X; Qiu J; Hong F; Gao F; Wang X; Zhang S
Aging (Albany NY); 2023 Feb; 15(4):1052-1073. PubMed ID: 36801818
[TBL] [Abstract][Full Text] [Related]
33. Age-associated downregulation of vasohibin-1 in vascular endothelial cells.
Takeda E; Suzuki Y; Sato Y
Aging Cell; 2016 Oct; 15(5):885-92. PubMed ID: 27325558
[TBL] [Abstract][Full Text] [Related]
34. Vasohibin-1 and -2 in pulmonary lymphangioleiomyomatosis (LAM) cells associated with angiogenic and prognostic factors.
Inoue C; Miki Y; Saito-Koyama R; Kobayashi K; Seyama K; Okada Y; Sasano H
Pathol Res Pract; 2022 Feb; 230():153758. PubMed ID: 35026646
[TBL] [Abstract][Full Text] [Related]
35. Long noncoding RNA RBMS3-AS3 acts as a microRNA-4534 sponge to inhibit the progression of prostate cancer by upregulating VASH1.
Jiang Z; Zhang Y; Chen X; Wu P; Chen D
Gene Ther; 2020 Apr; 27(3-4):143-156. PubMed ID: 31712637
[TBL] [Abstract][Full Text] [Related]
36. Depletion of Vasohibin 1 Speeds Contraction and Relaxation in Failing Human Cardiomyocytes.
Chen CY; Salomon AK; Caporizzo MA; Curry S; Kelly NA; Bedi K; Bogush AI; Krämer E; Schlossarek S; Janiak P; Moutin MJ; Carrier L; Margulies KB; Prosser BL
Circ Res; 2020 Jul; 127(2):e14-e27. PubMed ID: 32272864
[TBL] [Abstract][Full Text] [Related]
37. Overexpression of
Jiang S; Yang Y; Zhang Y; Ye Q; Song J; Zheng M; Li X
Dis Markers; 2022; 2022():9719671. PubMed ID: 35186171
[TBL] [Abstract][Full Text] [Related]
38. Vasohibin-1 has α-tubulin detyrosinating activity in glomerular podocytes.
Mifune T; Tanabe K; Nakashima Y; Tanimura S; Sugiyama H; Sato Y; Wada J
Biochem Biophys Res Commun; 2022 Apr; 599():93-99. PubMed ID: 35180473
[TBL] [Abstract][Full Text] [Related]
39. Vasohibin-1 expression as a biomarker of aggressive nature in ductal adenocarcinoma of the prostate: a retrospective cohort study at two centres in Japan.
Kobayashi H; Kosaka T; Mikami S; Kimura T; Hongo H; Kosugi M; Sato Y; Oya M
BMJ Open; 2021 Nov; 11(11):e056439. PubMed ID: 34819292
[TBL] [Abstract][Full Text] [Related]
40. Significance of CD47 and Its Association With Tumor Immune Microenvironment Heterogeneity in Ovarian Cancer.
Yu L; Ding Y; Wan T; Deng T; Huang H; Liu J
Front Immunol; 2021; 12():768115. PubMed ID: 34966389
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
